Funding Progress
$95,068 of a $1,200,000 goal
Be One of the First Investors — early movers shape the outcome
Invest: Minimum ($2500)
About Osteoboost Health
Osteoboost is the first and only FDA-cleared, drug-free prescription treatment for low bone density. With a $30B market of 64M patients suffering from osteopenia and osteoporosis, it’s a breakthrough bringing new hope to an aging population seeking science-backed solutions.
Inspired by NASA research, Osteoboost is the first at-home device clinically proven to slow vertebral bone loss by 85%. With $3M+ in sales, 2500+ prescribing physicians (including 30+ top academic centers), and the acquisition of the Wellen osteoporosis exercise program, Osteoboost is scaling quickly.
Through its Digital Care Program, Osteoboost combines therapy with reimbursable remote monitoring (>$1,250 annually). As an FDA Breakthrough Device with De Novo approval, it’s set to redefine the standard of care in bone health. Osteoboost's goal is to not only become the standard of care for low bone density, but to transform care for every woman entering menopause by stopping bone loss before it starts.
Themes & SDGs Supported
Mission and Vision
Osteoboost exists to transform the way bone health is prevented and treated by making safe, evidence-based, drug-free technology accessible to the millions of people at risk for osteoporosis before they experience a life-changing fracture. We envision a future where maintaining bone strength is as routine as managing heart health—where every person has access to proactive, personalized care that preserves mobility, independence, and quality of life as they age. By combining clinical innovation, digital health, and scalable care delivery, Osteoboost seeks to reduce the enormous human and economic burden of osteoporosis while advancing healthier aging, improving health equity for women, and enabling millions to live longer, stronger, and more active lives.
Investment Terms
To view Terms/Materials, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.
If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.
Investment Materials
To view Materials/Terms, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.
If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.
Funding Progress
$95,068 of a $1,200,000 goal
Be One of the First Investors — early movers shape the outcome
Put Your Capital to Work
Invest: Minimum ($2500)